ROIV - Immunovant to raise $450M from public offering and private placement
2023-09-28 07:31:31 ET
More on Immunovant, Roivant, etc.
- Immunovant: Immune Boost, From Clinical Trials To An Aggressive Bullish Stock
- Immunovant: Data Sizzles, But The Steak Isn't Done Yet (Rating Upgrade)
- Skin In The Game: Behind Roivant's Significant Rise
- Immunovant stock rallies for second day, fueled by public offering, drug data
- Immunovant announces proposed offering of $300M of common stock
For further details see:
Immunovant to raise $450M from public offering and private placement